文献速递乳腺癌妇科肿瘤支持与姑息治疗

2012年全球20-39岁年轻成人癌症发病与死亡负担

Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.
PubMed 文献 · Lancet Oncol · 2017-10-27

基于GLOBOCAN 2012数据,研究量化了全球184个国家20-39岁年轻成人癌症负担。女性乳腺癌、宫颈癌、甲状腺癌、白血病和结直肠癌为最常见新发病种,且负担随年龄、性别、发展水平和地理区域显著变化。

核心结论

  • 全球20-39岁年轻成人癌症负担与更年轻或更年长人群不同,且随年龄、性别、发展水平和地理区域显著变化。
  • 尽管该年龄组癌症负担低于更年长人群,但过早发病和死亡带来的社会与经济影响仍很大。
  • 需要针对这一服务不足的年龄组开展靶向监测、预防和治疗以减轻癌症负担。

研究设计与样本

  • 基于人群的研究,从IARC GLOBOCAN 2012提取全球、区域及184个国家2012年20-39岁年轻成人新发癌症病例和癌症相关死亡估计数。
  • 年轻成人癌症定义为20-39岁发生的癌症。
  • 按四个5岁年龄组、全部癌症合并及27种主要癌症类型(ICD-10定义)分析,并报告总体和按性别的病例数、死亡数及每10万人年年龄标化率(ASR)。
  • 按人类发展指数(HDI)四个水平(低、中、高、极高)呈现结果。

主要发现

  • 负担在女性中不成比例地更高。
  • 新发病例最常见癌症类型为女性乳腺癌、宫颈癌、甲状腺癌、白血病和结直肠癌;死亡主要贡献者为女性乳腺癌、肝癌、白血病和宫颈癌。
  • 按发展水平和地理区域评估,癌症谱差异显著;一般而言,转型地区感染相关癌症负担更大。

临床怎么用

  • 临床应关注20-39岁年轻成人癌症谱,女性乳腺癌、宫颈癌、甲状腺癌、白血病和结直肠癌为该人群常见新发癌症。
  • 在低HDI地区应特别关注感染相关癌症及较高的癌症死亡负担。
  • 针对该年龄组需加强靶向监测、预防和治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To date, the burden of cancer among young adults has rarely been studied in depth. Our aim was to describe the scale and profile of cancer incidence and mortality worldwide among 20-39 year-olds, highlighting major patterns by age, sex, development level, and geographical region. METHODS: We did a population-based study to quantify the burden of young adult cancers worldwide. We defined young adult cancers as those occurring between the ages of 20 and 39 years because these individuals will have passed puberty and adolescence, but not yet experienced the effects of hormonal decline, immune response deterioration, or organ dysfunction associated with chronic health conditions. Global, regional, and country-specific (n=184) data estimates of the number of new cancer cases and cancer-associated deaths that occurred in 2012 among young adults were extracted in four 5-year bands from the International Agency for Research on Cancer's GLOBOCAN 2012 for all cancers combined and for 27 major types as defined by the International Classification of Disease, tenth revision. We report the number of new cancer cases and cancer-associated deaths overall and by sex alongside corresponding age-standardised rates (ASR) per 100 000 people per year. We also present results using four levels of the Human Development Index (HDI; low [least developed], medium, high, and very high [most developed]), which is a composite indicator for socioeconomic development comprising life expectancy, education, and gross national income. FINDINGS: 975 396 new cancer cases and 358 392 cancer-associated deaths occurred among young adults worldwide in 2012, which equated to an ASR of 43·3 new cancer cases per 100 000 people per year and 15·9 cancer-associated deaths per 100 000 people per year. The burden was disproportionally greater among women and the most common cancer types overall in terms of new cases were female breast cancer, cervical cancer, thyroid cancer, leukaemia, and colorectal cancer; in terms of deaths, female breast cancer, liver cancer, leukaemia, and cervical cancer were the main contributors. When assessed by development level and geographical region, the cancer profile varied substantially; generally, the burden of infection-associated cancers was greater in regions under transition. Cancer incidence was elevated in very high-HDI regions compared with low-HDI regions (ASR 64·5 vs 46·2 cancer cases per 100 000 people per year); however, the mortality burden was 3 times higher in low-HDI regions (ASR 25·4 vs 9·2 cancer-associated deaths per 100 000 people per year), reflecting differences in cancer profiles and inferior outcomes. INTERPRETATION: The global cancer burden among 20-39 year-olds differs from that seen in younger or older ages and varies substantially by age, sex, development level, and geographical region. Although the cancer burden is lower in this age group than that observed in older ages, the societal and economic effects remain great given the major effects of premature morbidity and mortality. Targeted surveillance, prevention, and treatment are needed to reduce the cancer burden in this underserved age group. FUNDING: International Agency for Research on Cancer (IARC) and European Commission's FP-7 Marie Curie Actions-People-COFUND.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Fidler MM, Gupta S, Soerjomataram I, et al. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017. PMID: 29111259. doi:10.1016/S1470-2045(17)30677-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。